ASIAs largest health care company, the Singapore- based Parkway Group Healthcare has entered into a JV with the Mumbai-based Asian Heart Institute and Research Centre(AHIRC)to set up specialised centres of medical excellence in Mumbai. Parkway will hold a majority stake in the JV. The exact shareholding pattern is being firmed up. Parkway has entered into a management contract agreement with the promoters of AHIRC for managing and running the infrastruvture of the 250-bed heart hospital. As a first step, the Singapore company proposes to bring to India its internationally- acclaimed living donor liver transplant programme. The partnership will explore collaboration in oncology and orthopaedics. These super-speciality centres will be set up in AHIRCs Bandra-Kurla facility and will be cobranded by both the partners. Parkways entry into Mumbai forms part of its strategy to aggressively expand its footprint into India. It was in the fray for the acquisition of the Escorts Heart Institute and Research Centre in Delhi and plans to grow both through buy-outs and JVs. Parkway has also set up a PET-CT centre for advanced cancer diagnostics at Hyderabad. The $500m Parkway Group has recently acquired a controlling stake in Pantai Holdings, Malaysias largest health care provider. With this acquisition, the total number of hospitals under Parkways control has gone upto 15.
|
